Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024

SELL
$1.76 - $2.83 $2,720 - $4,375
-1,546 Reduced 10.59%
13,051 $33,000
Q2 2023

Aug 11, 2023

SELL
$2.1 - $3.36 $3,880 - $6,209
-1,848 Reduced 11.24%
14,597 $33,000
Q1 2023

May 02, 2023

SELL
$2.13 - $3.6 $6,715 - $11,350
-3,153 Reduced 16.09%
16,445 $42,000
Q3 2022

Nov 09, 2022

BUY
$0.63 - $5.47 $29 - $257
47 Added 0.24%
19,598 $57,000
Q2 2022

Aug 15, 2022

BUY
$4.27 - $8.26 $83,482 - $161,491
19,551 New
19,551 $88,000

Others Institutions Holding SLGC

About SomaLogic, Inc.


  • Ticker SLGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 183,452,992
  • Description
  • SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...
More about SLGC
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.